These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7518555)

  • 1. Benign prostatic hypertrophy. Options for management.
    Webb D
    Med J Aust; 1994 Aug; 161(3):179-80. PubMed ID: 7518555
    [No Abstract]   [Full Text] [Related]  

  • 2. Benign prostatic hyperplasia. Age and type of treatment.
    Bono AV; Fava C
    J Urol (Paris); 1995; 101(1):50-2. PubMed ID: 7545731
    [No Abstract]   [Full Text] [Related]  

  • 3. Benign prostatic hyperplasia (BPH) therapy: when? how? why? the take-home message.
    Marberger M
    J Urol (Paris); 1995; 101(1):56-7. PubMed ID: 7545734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of benign prostate hyperplasia].
    Romics I
    Orv Hetil; 2010 Mar; 151(12):506-8. PubMed ID: 20231135
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical management of benign prostatic hypertrophy.
    Geller J
    Compr Ther; 1994; 20(12):682-7. PubMed ID: 7533690
    [No Abstract]   [Full Text] [Related]  

  • 6. A 73-year-old man with symptomatic benign prostatic hyperplasia.
    Barry MJ
    JAMA; 1997 Dec 24-31; 278(24):2178-84. PubMed ID: 9417013
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of benign prostatic hypertrophy].
    Romics I
    Orv Hetil; 2003 Nov; 144(45):2229-30. PubMed ID: 14686009
    [No Abstract]   [Full Text] [Related]  

  • 8. Current treatment options for benign prostatic hyperplasia and their impact on sexual function.
    Larson TR
    Urology; 2003 Apr; 61(4):692-8. PubMed ID: 12670545
    [No Abstract]   [Full Text] [Related]  

  • 9. Benign prostatic hyperplasia. Medical and minimally invasive treatment options.
    Oesterling JE
    N Engl J Med; 1995 Jan; 332(2):99-109. PubMed ID: 7527494
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
    Agha AH; Roy JB; Culkin DJ; Lyon K
    Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic trends in benign hypertrophy of the prostate].
    Chatelain C
    Chirurgie; 1999 Jun; 124(3):223-31. PubMed ID: 10429295
    [No Abstract]   [Full Text] [Related]  

  • 12. Benign prostatic hyperplasia (BPH).
    Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy.
    Bredin HC
    Ir Med J; 1996; 89(3):86, 88. PubMed ID: 8707527
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R; Thalmann G; Reich O; Steif CG
    Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic controversies: clinical treatment of benign prostatic hyperplasia.
    Geller J; Kirchenbaum A; Lepor H; Levine AC
    J Clin Endocrinol Metab; 1995 Mar; 80(3):745-7. PubMed ID: 7533770
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating benign prostatic hyperplasia with medications.
    Long K; Long R
    Nurse Pract Forum; 1994 Sep; 5(3):126-7. PubMed ID: 7524871
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality-of-life aspects in urology - benign prostatic hyperplasia.
    MacDonagh R; Pearcy R
    World J Urol; 1999 Aug; 17(4):199-204. PubMed ID: 10460401
    [No Abstract]   [Full Text] [Related]  

  • 18. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
    McConnell JD; Roehrborn CG; Bautista OM; Andriole GL; Dixon CM; Kusek JW; Lepor H; McVary KT; Nyberg LM; Clarke HS; Crawford ED; Diokno A; Foley JP; Foster HE; Jacobs SC; Kaplan SA; Kreder KJ; Lieber MM; Lucia MS; Miller GJ; Menon M; Milam DF; Ramsdell JW; Schenkman NS; Slawin KM; Smith JA;
    N Engl J Med; 2003 Dec; 349(25):2387-98. PubMed ID: 14681504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination drug therapy for benign prostatic hyperplasia.
    Kreder KJ
    JAMA; 1995 Jul; 274(4):359. PubMed ID: 7541871
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.
    Eri LM; Tveter KJ
    Drugs Aging; 1997 Feb; 10(2):107-18. PubMed ID: 9061268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.